ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

ivacaftor

Also written as “IVA”, “Ivacaftor” and “ELX/TEZ/IVA”.

Its studies are mostly in Cystic Fibrosis · Ciliary Motility Disorders, led by 3 companies.

Drug pageIvacaftor: every studyAll 94 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Aug 15, 201678 company-led studies, 4 open or runningNext primary completion: Apr 6, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Vertex Pharmaceuticals744 open or runningphase 4since Aug 15, 2016Apr 5, 2007Apr 6, 2027phase 3 · NCT05331183
Sun Pharmaceutical Industriesits history only30 open or runningphase 1since Mar 5, 2015Mar 5, 2015none ahead
Parion Sciencesits history only10 open or runningphase 2since Aug 12, 2016Aug 12, 2016none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Vertex Pharmaceuticals only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 47 studies since Feb 1, 2012.

  1. Aug 28, 2020Phase 3 study in Cystic FibrosisNCT04537793 · 83 enrolled · United States, Australia, Canada and more
  2. Sep 3, 2020Phase 3 study in Cystic FibrosisNCT04545515 · 120 enrolled · Australia, Canada, Denmark and more
  3. Oct 21, 2020Phase 3 study in Cystic FibrosisNCT04599465 · 69 enrolled · Australia, Belgium, Czechia and more
  4. Jul 9, 2021Phase 3 study in Cystic FibrosisNCT04969224 · 82 enrolled · Australia, Belgium, Canada and more
  5. Oct 27, 2021Phase 3 study in Cystic FibrosisNCT05111145 · 86 enrolled · Australia, Belgium, Canada and more
  6. Nov 29, 2021Phase 3 study in Cystic FibrosisNCT05153317 · 71 enrolled · United States, Australia, Canada and more
  7. Mar 1, 2022Phase 3 study in Cystic FibrosisNCT05274269 · 307 enrolled · Austria, Belgium, Canada and more
  8. Apr 8, 2022Phase 3 study in Cystic FibrosisNCT05331183 · 297 enrolled · Austria, Belgium, Canada and more
  9. May 19, 2023Phase 3 study in Cystic FibrosisNCT05882357 · 67 enrolled · Australia, Canada, Denmark and more
  10. Nov 23, 2023Phase 1 study in Cystic FibrosisNCT06154447 · 165 enrolled · United States
  11. Jun 10, 2024Phase 3 study in Cystic FibrosisNCT06460506 · 50 enrolled · Australia, Canada, Denmark and more
  12. Dec 4, 2025Phase 1 study in Cystic FibrosisNCT07283770 · 152 planned · United States
  13. Feb 20, 2026Phase 1 study in Cystic FibrosisNCT07437105 · 160 planned · United States
  14. Oct 19, 2026Primary completion moved from 2026-11-19 to 2027-07-12Date moved laterphase 1 · +8 months · NCT07283770

Ahead

  1. Apr 6, 2027Primary completion: phase 3 study in Cystic FibrosisNCT05331183
  2. Jun 26, 2027Primary completion: phase 1 study in Cystic FibrosisNCT07437105
  3. Jul 12, 2027Primary completion: phase 1 study in Cystic FibrosisNCT07283770
  4. Sep 30, 2027Primary completion: phase 3 study in Cystic FibrosisNCT06460506

TargetBeta

CFTR →read by rule
“Cystic fibrosis transmembrane conductance regulator positive modulator; Cystic fibrosis transmembrane conductance regulator activator”ChEMBL 37, by rule

Other programs on CFTR

ProgramCompanyFurthest phaseStudies
lumacaftorruleVertex Pharmaceuticalsphase 423
tezacaftorruleVertex Pharmaceuticalsphase 339

Studies

The newest 60 of 74 Vertex Pharmaceuticals leads. Each opens its study page. Every study on its drug page →

StudyPhaseStatusPrimary completionSize
NCT07437105Cystic Fibrosis · United States1RecruitingJun 26, 2027160
NCT07283770Cystic Fibrosis · United States1RecruitingJul 12, 2027152
NCT06460506Cystic Fibrosis · Australia, Canada, Denmark and more3Active, not recruitingSep 30, 202750
NCT06154447Cystic Fibrosis · United States1CompletedJul 10, 2026165
NCT05882357Cystic Fibrosis · Australia, Canada, Denmark and more3CompletedSep 4, 202567
NCT05331183Cystic Fibrosis · Austria, Belgium, Canada and more3Active, not recruitingApr 6, 2027297
NCT05274269Cystic Fibrosis · Austria, Belgium, Canada and more3CompletedJul 5, 2023307
NCT05153317Cystic Fibrosis · United States, Australia, Canada and more3CompletedJan 29, 202671
NCT05111145Cystic Fibrosis · Australia, Belgium, Canada and more3CompletedDec 20, 202286
NCT04969224Cystic Fibrosis · Australia, Belgium, Canada and more3CompletedJul 26, 202282
NCT04599465Cystic Fibrosis · Australia, Belgium, Czechia and more3CompletedJul 14, 202269
NCT04545515Cystic Fibrosis · Australia, Canada, Denmark and more3CompletedMar 24, 2023120
NCT04537793Cystic Fibrosis · United States, Australia, Canada and more3CompletedJun 3, 202283
NCT04362761Cystic Fibrosis · Australia, Belgium, Germany and more3CompletedDec 21, 2022172
NCT04353817Cystic Fibrosis · Australia, Canada, Denmark and more3CompletedMay 17, 2021121
NCT04235140Cystic Fibrosis · United States, Canada3CompletedAug 22, 202352
NCT04183790Cystic Fibrosis · United States, Australia, Canada and more3CompletedFeb 24, 202464
NCT04058366Cystic Fibrosis · United States, Australia, Belgium and more3CompletedDec 16, 2022251
NCT03911713Cystic Fibrosis · United States, Australia, Belgium and more2CompletedAug 20, 202077
NCT03768089Cystic Fibrosis · Netherlands, United Kingdom2CompletedMay 3, 2019115
NCT03691779Cystic Fibrosis · United States, Australia, Canada and more3CompletedAug 7, 202071
NCT03625466Cystic Fibrosis · Germany2CompletedOct 9, 202051
NCT03633526Cystic Fibrosis · United States3TerminatedJan 18, 201918
NCT03601637Cystic Fibrosis · United States, Canada3CompletedOct 29, 202161
NCT03559062Cystic Fibrosis · Australia, Belgium, Denmark and more3CompletedDec 21, 201867
NCT03537651Cystic Fibrosis · United States, Australia, Belgium and more3CompletedOct 28, 2020130
NCT03486236Cystic Fibrosis · United Kingdom1CompletedSep 14, 201616
NCT03277196Cystic Fibrosis · United States, Australia, Canada and more3CompletedOct 2, 202386
NCT03224351Cystic Fibrosis · United States, Ireland, Israel and more2CompletedFeb 28, 2018124
NCT03150719Cystic Fibrosis · United States, France, Germany3CompletedAug 9, 201898
NCT03125395Cystic Fibrosis · United States, Canada3CompletedJul 17, 201957
NCT03068312Cystic Fibrosis · Israel3CompletedDec 18, 201838
NCT03061331Cystic Fibrosis · Netherlands2CompletedSep 6, 201720
NCT02971839Cystic Fibrosis · United States2TerminatedAug 201711
NCT02951195Cystic Fibrosis · United States2CompletedJan 201880
NCT02951182Cystic Fibrosis · United States, Australia, Austria and more2CompletedAug 201774
NCT02875366Cystic Fibrosis · Australia, United Kingdom4CompletedSep 201770
NCT02742519Cystic Fibrosis · Australia, Canada, United Kingdom3TerminatedAug 201714
NCT02730208Cystic Fibrosis · Australia2CompletedJul 201841
NCT02725567Cystic Fibrosis · United States, Australia, Canada and more3CompletedJun 28, 202257
NCT02565914Cystic Fibrosis · United States, Australia, Austria and more3CompletedMay 20191,131
NCT02544451Cystic Fibrosis · United States, Australia, Belgium and more3CompletedAug 2018246
NCT02516410Cystic Fibrosis · United States, Australia, Austria and more3CompletedJun 7, 2016168
NCT02514473Cystic Fibrosis · United States, Australia, Belgium and more3CompletedSep 2016206
NCT02508207Cystic Fibrosis · United States2CompletedJun 201734
NCT02412111Cystic Fibrosis · United States, Australia, Austria and more3CompletedSep 2017156
NCT02392234Cystic Fibrosis · United States, Australia, Belgium and more3CompletedFeb 2017248
NCT02347657Cystic Fibrosis · United States, Canada, Denmark and more3CompletedJan 20, 2017510
NCT02015507Cystic Fibrosis1CompletedFeb 201434
NCT01946412Cystic Fibrosis · United States, Canada, United Kingdom3CompletedDec 201533
NCT01931839Cystic Fibrosis · United States, Australia, Austria and more3CompletedApr 20161,164
NCT01807949Cystic Fibrosis · United States, Australia, Austria and more3CompletedApr 2014563
NCT01807923Cystic Fibrosis · United States, Australia, Canada and more3CompletedApr 2014559
NCT01768663Cystic Fibrosis · United States1CompletedSep 201380
NCT01707290Cystic Fibrosis · United States, Belgium, France and more3CompletedApr 2016125
NCT01705145Cystic Fibrosis · United States, Canada, United Kingdom3CompletedMar 201435
NCT01685801Cystic Fibrosis · United States2CompletedApr 201424
NCT01614470Cystic Fibrosis · United States, Belgium, France3CompletedOct 201339
NCT01614457Cystic Fibrosis · United States, United Kingdom3CompletedOct 201370
NCT01531673Cystic Fibrosis · United States, Canada, Germany and more2CompletedMar 2014194

How it is read

Names in the registry

  • “IVA”, 26 entries
  • “Ivacaftor”, 26 entries
  • “ELX/TEZ/IVA”, 14 entries
  • “VX-770”, 10 entries
  • “LUM/IVA”, 8 entries

Codes read as this program: VX770.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.